Literature DB >> 11063746

Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.

M L Cunningham1, G L Waldo, S Hollinger, J R Hepler, T K Harden.   

Abstract

RGS proteins (regulators of G protein signaling) attenuate heterotrimeric G protein signaling by functioning as both GTPase-activating proteins (GAPs) and inhibitors of G protein/effector interaction. RGS2 has been shown to regulate Galpha(q)-mediated inositol lipid signaling. Although purified RGS2 blocks PLC-beta activation by the nonhydrolyzable GTP analog guanosine 5'-O-thiophosphate (GTPgammaS), its capacity to regulate inositol lipid signaling under conditions where GTPase-promoted hydrolysis of GTP is operative has not been fully explored. Utilizing the turkey erythrocyte membrane model of inositol lipid signaling, we investigated regulation by RGS2 of both GTP and GTPgammaS-stimulated Galpha(11) signaling. Different inhibitory potencies of RGS2 were observed under conditions assessing its activity as a GAP versus as an effector antagonist; i.e. RGS2 was a 10-20-fold more potent inhibitor of aluminum fluoride and GTP-stimulated PLC-betat activity than of GTPgammaS-promoted PLC-betat activity. We also examined whether RGS2 was regulated by downstream components of the inositol lipid signaling pathway. RGS2 was phosphorylated by PKC in vitro to a stoichiometry of approximately unity by both a mixture of PKC isozymes and individual calcium and phospholipid-dependent PKC isoforms. Moreover, RGS2 was phosphorylated in intact COS7 cells in response to PKC activation by 4beta-phorbol 12beta-myristate 13alpha-acetate and, to a lesser extent, by the P2Y(2) receptor agonist UTP. In vitro phosphorylation of RGS2 by PKC decreased its capacity to attenuate both GTP and GTPgammaS-stimulated PLC-betat activation, with the extent of attenuation correlating with the level of RGS2 phosphorylation. A phosphorylation-dependent inhibition of RGS2 GAP activity was also observed in proteoliposomes reconstituted with purified P2Y(1) receptor and Galpha(q)betagamma. These results identify for the first time a phosphorylation-induced change in the activity of an RGS protein and suggest a mechanism for potentiation of inositol lipid signaling by PKC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063746     DOI: 10.1074/jbc.M007699200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.

Authors:  Jiaxin Niu; Astrid Scheschonka; Kirk M Druey; Amanda Davis; Eleanor Reed; Vladimir Kolenko; Richard Bodnar; Tatyana Voyno-Yasenetskaya; Xiaoping Du; John Kehrl; Nickolai O Dulin
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Novel role of RGS2 in regulation of antioxidant homeostasis in neuronal cells.

Authors:  Samina Salim; Mohammad Asghar; Manish Taneja; Iiris Hovatta; Yuh-Lin Wu; Kaustuv Saha; Nada Sarraj; Brian Hite
Journal:  FEBS Lett       Date:  2011-04-16       Impact factor: 4.124

Review 3.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

4.  Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor.

Authors:  Rosa V Flores; Melvin G Hernández-Pérez; Edna Aquino; Richard C Garrad; Gary A Weisman; Fernando A Gonzalez
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

Review 5.  Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways.

Authors:  Esmerilda G Delicado; M Teresa Miras-Portugal; Luz María G Carrasquero; David León; Raquel Pérez-Sen; Javier Gualix
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

6.  A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.

Authors:  Julien Dusonchet; Hu Li; Maria Guillily; Min Liu; Klodjan Stafa; Claudio Derada Troletti; Joon Y Boon; Shamol Saha; Liliane Glauser; Adamantios Mamais; Allison Citro; Katherine L Youmans; LiQun Liu; Bernard L Schneider; Patrick Aebischer; Zhenyu Yue; Rina Bandopadhyay; Marcie A Glicksman; Darren J Moore; James J Collins; Benjamin Wolozin
Journal:  Hum Mol Genet       Date:  2014-05-02       Impact factor: 6.150

Review 7.  The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.

Authors:  B Sjögren
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

8.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

9.  Spinal adenosine A2(A) receptor inhibition enhances phrenic long term facilitation following acute intermittent hypoxia.

Authors:  M S Hoffman; F J Golder; S Mahamed; G S Mitchell
Journal:  J Physiol       Date:  2009-11-09       Impact factor: 5.182

Review 10.  Coordinating speed and amplitude in G-protein signaling.

Authors:  Elliott M Ross
Journal:  Curr Biol       Date:  2008-09-09       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.